Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 15.83 USD 0.06% Market Closed
Market Cap: 2B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neogenomics Inc
Income from Continuing Operations Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Income from Continuing Operations
-$78.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Income from Continuing Operations
$6.2B
CAGR 3-Years
-10%
CAGR 5-Years
11%
CAGR 10-Years
14%
Danaher Corp
NYSE:DHR
Income from Continuing Operations
$3.6B
CAGR 3-Years
-15%
CAGR 5-Years
11%
CAGR 10-Years
3%
Mettler-Toledo International Inc
NYSE:MTD
Income from Continuing Operations
$785.7m
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
10%
Agilent Technologies Inc
NYSE:A
Income from Continuing Operations
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
5%
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Income from Continuing Operations
$1.4B
CAGR 3-Years
22%
CAGR 5-Years
39%
CAGR 10-Years
16%

See Also

What is Neogenomics Inc's Income from Continuing Operations?
Income from Continuing Operations
-78.5m USD

Based on the financial report for Jun 30, 2024, Neogenomics Inc's Income from Continuing Operations amounts to -78.5m USD.

What is Neogenomics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
32%

Over the last year, the Income from Continuing Operations growth was 32%.

Back to Top